Latus Pharma ApS

CVR 36974214 · Private limited company (ApS) · Active · Low risk

Latus Pharma ApS is a Private limited company (ApS), founded on , based in Køge. The company is registered in the industry andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 10 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 83k and a net result of DKK -6,991. CEO: Jørgen Wittendorff.

Bankruptcy risk for Latus Pharma ApS

0.2%
probability of bankruptcy within 12 months
Low risk

0.2 × the average (1.41%) · higher risk than 49% of active Danish companies

Lowest riskHighest risk

Increases the risk

Reporting classReporting class B, mikrovirksomhed · bankruptcy rate 23.5%2.7×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Equity vs. share capital1× · bankruptcy rate 12.9%1.5×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Website registeredYes · bankruptcy rate 12.0%1.4×
CEO's other companies0 · bankruptcy rate 10.9%1.2×

Reduces the risk

Published annual reports10+ · bankruptcy rate 3.0%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Return on assets-20%–0% · bankruptcy rate 6.2%0.70×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
36974214
Status
Active
Company type
Private limited company (ApS)
Founded
(11 years)
Address
Birkevej 4
4600 Køge
Municipality
Stevns
Industry
Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749990)
Bankruptcies in the industry: Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.
Share capital
DKK 50k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 10
Missing annual reportNo
Negative equityNo
Equity ratio100.0%
Current ratio–
Moves (last 2 years)1
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address0
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
RevenueDKK -6,991DKK -6,897DKK 0
Gross profitDKK -6,991DKK -6,897DKK -11k
Net profitDKK -6,991DKK -6,897DKK -11k
EquityDKK 83kDKK 88kDKK 94k
Total assetsDKK 83kDKK 88kDKK 94k
CashDKK 82kDKK 88k–

Latest annual report: Reporting class B, mikrovirksomhed · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025148
1 Jan 2024 – 31 Dec 2024153
1 Jan 2023 – 31 Dec 2023180
1 Jan 2022 – 31 Dec 2022175
1 Jan 2021 – 31 Dec 2021150
1 Jan 2020 – 31 Dec 2020151
1 Jan 2019 – 31 Dec 2019152
1 Jan 2018 – 31 Dec 2018149
1 Jan 2017 – 31 Dec 2017151
28 Jul 2015 – 31 Dec 2016171

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOJørgen WittendorffCurrent
Owner (100%)Jørgen WittendorffCurrent
FounderJørgen WittendorffCurrent

The CEOs' other companies

Jørgen Wittendorff – 1 other companies

Address history (3 moves)

Birkevej 4, 4600 Køge
Boestoftevej 13, 4673 Rødvig Stevns
Ribsvej 7B, 4540 Fårevejle
Skovbuen 65, 2605 Brøndby

Similar companies in Stevns

Questions and answers about Latus Pharma ApS

Has Latus Pharma ApS gone bankrupt?

No, Latus Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Latus Pharma ApS?

Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.

Who is the CEO of Latus Pharma ApS?

Jørgen Wittendorff is the CEO of Latus Pharma ApS.

When was Latus Pharma ApS founded?

Latus Pharma ApS was founded on 28 July 2015.

What is the equity of Latus Pharma ApS?

Equity was DKK 83k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.